Gyeonggi-do, South Korea

Kyoung-Jin O

This inventor holds 1 USPTO granted patent. Top assignee: Jw Pharmaceutical Corporation. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyoung-Jin O. Retrieved from https://idiyas.com/inventor/kyoung-jin-o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kyoung-Jin O: Innovator in Pharmaceutical Crystallization

Introduction

Kyoung-Jin O is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of drug crystallization. His work has implications for the development of effective medications.

Latest Patents

Kyoung-Jin O holds a patent for a novel crystal of doripenem, titled "Crystal of doripenem, and preparation method therefor." This invention relates to a unique doripenem crystal, including a solvate and a preparation method. Specifically, it focuses on a doripenem anhydride crystal and the methods for preparing it using various solvents.

Career Highlights

Kyoung-Jin O is associated with Jw Pharmaceutical Corporation, where he applies his expertise in pharmaceutical research and development. His innovative work has contributed to advancements in drug formulation and delivery.

Collaborations

Kyoung-Jin O has collaborated with notable colleagues, including Do-Kyu Pyun and Sang-A Lee. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Kyoung-Jin O's contributions to pharmaceutical innovation, particularly through his patent on doripenem crystals, highlight his role as a key inventor in the industry. His work continues to influence the development of effective pharmaceutical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…